Display screen with a graphical user interface
Latest Eli Lilly and Company Patents:
- MODIFIED OLIGONUCLEOTIDES
- Oxyntomodulin binding molecules, and uses thereof
- Pharmaceutical combinations comprising insulin and at least an agent selected from meloxicam, bromfenac sodium, acetylsalicylic acid, salicyclic acid and paracetamol
- Cocrystalline forms of FGFR3 inhibitors
- Drug container systems including lock-out mechanisms
Description
The FIGURE is a front view of a display screen with a graphical user interface showing the new design.
The broken lines of uneven length show the display screen and form no part of the claimed design.
Claims
The ornamental design for the display screen with a graphical user interface, as shown and described.
Referenced Cited
U.S. Patent Documents
| D709917 | July 29, 2014 | Faulkner |
| D732574 | June 23, 2015 | Capela |
| D759117 | June 14, 2016 | Liang |
| D766312 | September 13, 2016 | Hedges |
| D777785 | January 31, 2017 | Kim |
| D823859 | July 24, 2018 | Boyd |
| D854043 | July 16, 2019 | van Zyl |
| D857750 | August 27, 2019 | Rowe |
| D859446 | September 10, 2019 | Westerhold |
| D880497 | April 7, 2020 | Boyd |
| D882625 | April 28, 2020 | Dixit |
| D910072 | February 9, 2021 | Cazamias |
| D931898 | September 28, 2021 | Demar |
Patent History
Patent number: D981451
Type: Grant
Filed: May 13, 2021
Date of Patent: Mar 21, 2023
Assignee: Eli Lilly and Company (Indianapolis, IN)
Inventor: Korey Allen Clements (Fishers, IN)
Primary Examiner: Nicole C Shiflet
Application Number: 29/783,501
Type: Grant
Filed: May 13, 2021
Date of Patent: Mar 21, 2023
Assignee: Eli Lilly and Company (Indianapolis, IN)
Inventor: Korey Allen Clements (Fishers, IN)
Primary Examiner: Nicole C Shiflet
Application Number: 29/783,501
Classifications
Current U.S. Class:
Humanoid (D14/495)
